ClinicalTrials.gg
CompletedNCT03328689Back2LiveWelUpdated Feb 21, 2020

Back2LiveWell: Community Based Prevention of Back Pain Flare-ups

An interventional study of Physical activity program and Control group standard care in Low Back Pain, Recurrent and Low Back Pain, sponsored by McMaster University. Completed at 1 site in Canada. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-02-21.

Sponsored by McMaster University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 82 studies in Low Back Pain with a site in Canada — 11 open to participants now, 12 under way, none of them phase 3. Low Back Pain · Canada.

Enrollment
57th of 66
17 · median 61
Started
2018
with 4 others
No phase
52 of 82
6 open now
Registered
36th of 82
by date
Lead sponsor
6 of 82
McMaster University

Among the 82 studies in Low Back Pain with a site in Canada, this one is the 57th largest by enrollment of the 66 interventional ones that give a count, is one of 5 that started in 2018, is one of 52 with no phase, and was the 36th registered.

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

11 of the 82 studies in Low Back Pain with a site in Canada are open now. Recruiting first, the newest first:

6 more — sign in →

All 11 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 333 Low Back Pain studies recruiting now, 92 (28%) set no upper age limit and 211 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 82 studies in Low Back Pain with a site in Canada, or all of them as a file.
02

Study summary

The primary objective of this study is to compare the effectiveness and cost-effectiveness of an individualized group based exercise and education program supported in the community to a control group of usual care in preventing back pain flare-ups and to mitigate the negative consequences of subsequent episodes if they occur.

Read the detailed description

Secondary objectives are to:

  • To compare the effectiveness of the two interventions in preventing an activity-limiting LBP flare up at 12 and 24 months.

Secondary objectives are to:

  • To compare the effectiveness of the interventions in mitigating the negative consequences of LBP.
  • To evaluate the cost-effectiveness of the interventions in preventing activity-limiting LBP flare-up.
  • To identify subgroups of individuals that may best respond to each one of the two interventions.

Exploratory objectives include:

  • evaluate the fluctuating nature of back pain using a smart phone application to collect pain measures once a week for 1 year (trajectories will also be evaluated to compare between group effects)
  • assess adherence to physical activity using activity monitors.
  • evaluate the relationship between activity levels and flare-ups as a method for understanding pain triggers and impact of activity pacing.
03

Conditions studied

  • Low Back Pain, Recurrent
  • Low Back Pain

Keywords

  • prevention
  • exercise
  • randomized controlled trial
  • physical activity
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants will be included if they meet the following criteria

  • Have been discharged \<3 months from physiotherapy, chiropractic or osteopathic care following a course of treatment for LBP (pain in the area between the 12th rib and buttock crease)
  • Have non-specific LBP which is pain not attributed to a specific diagnosis such as sciatica, ankylosing spondylitis, vertebral fracture, etc.
  • Non-specific LBP sometimes called mechanical LBP accounts for \~85% of LBP diagnosis.
  • Between 18 and 80 years of age

Exclusion criteria

Exclusion criteria:

Participants will be excluded if they meet the following criteria:

  • Ongoing high pain intensity, defined as pain intensity of 6 or more on a 0-10 point scale. The cut off of 6/10 is used in the literature to dichotomise low/moderate to high pain intensity.
  • Co-morbidity preventing participation in physical activity evaluated using the Physical Activity Readiness Questionnaire (PAR-Q) from the American College of Sports Medicine guidelines
  • Inadequate English to complete outcome measures
  • Currently participating in an exercise program similar to the one we will evaluate.
  • History of spine surgery
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
17 participants (actual)

Study arms

  • Experimental
    Physical activity in the community

    The physical activity program will include an individualized exercise program delivered in community exercise facility plus education..

    Other: Physical activity program

  • Active comparator
    Control group standard care

    Participants from the control group will receive no additional intervention other than being encouraged to continue with their physiotherapists or chiropractor recommendation which will often include recommendation to keep activity, home exercise programs and advice to engage in physical activity.

    Other: Control group standard care

Interventions

  • OtherPhysical activity program

    This arm will begin with PT assessment. Following this, participants will meet with a specialist who will design an individualized physical activity program. Classes will include warm up, 40 minutes of individualized exercises and a cool down that will include back pain specific exercises including core strengthening. The first 4 weeks of exercise will include a 30-minute education program. Education comprise information on back pain, efficient use of the back during daily activities, self-management, self-efficacy and pain neurophysiology. Classes will run for a 12-week period. Participants will be encouraged to attend the exercise facility at least 3 times a week. An activity monitor will be provided to all participants. We will use group classes to facilitate the development of social support.

  • OtherControl group standard care

    Participants from the control group will receive usual care which will often include recommendation to keep activity, home exercise programs and advice to engage in physical activity. Participants in the control group will also receive and activity monitor for collection of physical activity data. This activity monitor may also be used for positive feedback and activity reinforcement

06

What researchers measure

Primary outcomes

  1. Activity limiting flare-up

    * flare-up is an increase in pain levels of greater than or equal to 3 on a 0-10 numeric pain scale. The LBP international consensus on minimal important change in pain is 2 on a 0-10 scale and thus a change of 3 is likely be clinically important.15 * activity-limiting LBP will be measured using an adaptation of the item PI9 of the PROMIS item bank. (How much did LBP interfere with your day to day activities?) A score of 3 or greater (representing somewhat impact) on a 1-5 scale will be considered as activity limitation. Participants will fit the criteria for activity-limiting flare-up if pain increases at least 3 points AND pain is identified to be limiting on the PI9 as described above. Flare-up will be collected once a week for 1 year

    Time frame: 12 months

Secondary outcomes

  1. Activity limiting flare-up

    * flare-up is an increase in pain levels of greater than or equal to 3 on a 0-10 numeric pain scale. The LBP international consensus on minimal important change in pain is 2 on a 0-10 scale and thus a change of 3 is likely be clinically important.15 * activity-limiting LBP will be measured using an adaptation of the item PI9 of the PROMIS item bank. (How much did LBP interfere with your day to day activities?) A score of 3 or greater (representing somewhat impact) on a 1-5 scale will be considered as activity limitation. Participants will fit the criteria for activity-limiting flare-up if pain increases at least 3 points AND pain is identified to be limiting on the PI9 as described above. Flare-up will be collected once a week for 1 year

    Time frame: 3 and 6 months

  2. Personal Impact of low back pain

    the outcome combines 9 items from the Patient Reported Outcome Measurement Information System (PROMIS) short form and covers the domains of pain intensity, pain interference with normal activities and functional status widely recommended in consensus documents on outcome measures for back pain

    Time frame: 3, 6, 12 months

  3. Pain intensity _NRS pain

    Pain intensity over the last week will be measured using a numeric rating scale 0-10 where 0 is not pain and 10 is worse pain

    Time frame: 3, 6, 12 months

  4. Disability

    Roland Morris Disability Questionnaire is a scale from 0-24 assessing pain related disability where 0 is no disability and 24 is significant disability

    Time frame: 3, 6, 12 months

  5. Function

    Patient Specific Functional Scale is a self reported scale assessing function on a scale from 0-10 where 0 is not able to perform the activity and 10 is able without pain

    Time frame: 3, 6, 12 months

  6. Health related Quality of Life: EQ-5D-5L

    EQ-5D-5L

    Time frame: 3, 6, 12 months (0-100)

  7. Physical activity questionnaire

    IPAQ_short form

    Time frame: 3, 6, 12 months

  8. Physical activity level

    Activity level measured using Garmin physical activity monitor

    Time frame: 3, 6, 12 months

07

Study locations

1 site
  • YMCA Hamilton
    Hamilton, Ontario, Canada
08

References and documents

Publications

  • Macedo LG, Richardson J, Battie MC, Hancock M, Kwan M, Hladysh G, Zhuo L. Back to living well: community-based management of low back pain: a feasibility study. Pilot Feasibility Stud. 2021 Jun 24;7(1):134. doi: 10.1186/s40814-021-00863-7. PubMed 34167584 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2018 to primary completion in Dec 2019, 13 months.

Of 1,231 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 13 months is above that.

Counting every sponsor, half of 1,286 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 23, 2017
First posted
Nov 1, 2017
StartActual
Nov 25, 2018
Primary completionActual
Dec 31, 2019
CompletionActual
Dec 31, 2019
Last update
Feb 21, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 21, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03328689
Collaborators
Macquarie University, Australia, University of Alberta, Universidade Federal do Ceara
Responsible party
Luciana Macedo (Assistant Professor, McMaster University) — Principal investigator
First posted
Nov 1, 2017
Start date
Nov 25, 2018
Primary completion
Dec 31, 2019
Completion
Dec 31, 2019
Last update
Feb 21, 2020

Study contacts

Luciana Macedo, PhD
principal investigator · McMaster University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion